These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30904464)

  • 1. Cystic fibrosis in the modern therapeutic era: Give the shower a thought!
    Le Pennec D; Baravalle-Einaudi M; Dupont C; Vecellio L; Dubus JC;
    J Cyst Fibros; 2019 Nov; 18(6):e56-e57. PubMed ID: 30904464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
    Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
    Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
    Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG; Gembitskaia TE
    Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulizer cleaning and disinfection practices in families with cystic fibrosis: The relationship between attitudes, practice and microbe colonization.
    Murray TS; O'Rourke TK; Feinn R; Drapeau G; Collins MS
    J Cyst Fibros; 2019 Nov; 18(6):823-828. PubMed ID: 31126899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):51-2. PubMed ID: 23797798
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):215-25. PubMed ID: 10536250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized antibiotics in cystic fibrosis: an update.
    Fiel SB
    Expert Rev Respir Med; 2014 Jun; 8(3):305-14. PubMed ID: 24838090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
    Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
    J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis.
    Coates AL; Denk O; Leung K; Ribeiro N; Chan J; Green M; Martin S; Charron M; Edwardes M; Keller M
    Pediatr Pulmonol; 2011 Apr; 46(4):401-8. PubMed ID: 21438171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.
    Hamed K; Debonnett L
    Ther Adv Respir Dis; 2017 May; 11(5):193-209. PubMed ID: 28470103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output.
    Collins MS; O'Brien M; Schramm CM; Murray TS
    J Cyst Fibros; 2019 Mar; 18(2):233-235. PubMed ID: 30224332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does repeated disinfection of the e-Flow rapid nebulizer affect in vitro performance?
    Bakuridze L; Andrieu V; Dupont C; Dubus JC
    J Cyst Fibros; 2007 Jul; 6(4):309-10. PubMed ID: 17276148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nebulized antibiotics in treating serious respiratory infections.
    Cole PJ
    J Chemother; 2001 Aug; 13(4):354-62. PubMed ID: 11589477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
    Hohenwarter K; Prammer W; Aichinger W; Reychler G
    J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi.
    Poli G; Acerbi D; Pennini R; Soliani Raschini A; Corrado ME; Eichler HG; Eichler I
    Paediatr Drugs; 2007; 9 Suppl 1():3-9. PubMed ID: 17536870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thinking inside the box: nebulizer care, safe storage, and risk of infection in cystic fibrosis.
    Alexander L; Carson J; McCaughan J; Moore JE; Millar BC
    J Bras Pneumol; 2020 Apr; 46(2):e20190226. PubMed ID: 32294716
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.
    van Velzen AJ; Bos AC; Touw DJ; Tiddens HA; Heijerman HG; Janssens HM
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):273-80. PubMed ID: 26716357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis.
    Somayaji R; Parkins MD
    Ther Deliv; 2015 Feb; 6(2):121-37. PubMed ID: 25690082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.